Document is current

Any future updates will be listed below

Correction: Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy

Crossref DOI link: https://doi.org/10.1186/s13046-023-02703-3

Published Online: 2023-05-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark